CytomX Therapeutics
CTMX
CTMX
114 hedge funds and large institutions have $275M invested in CytomX Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 45 reducing their positions, and 17 closing their positions.
Holders
114
Holders Change
-8
Holders Change %
-6.56%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
36
Reduced
45
Closed
17
Calls
$9K
Puts
$222K
Net Calls
-$213K
Net Calls Change
+$6K
Top Buyers
Top Sellers
| 1 |
PA
1
Perceptive Advisors
New York
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
3
Squarepoint
New York
|
$202K |
| 4 |
4
State Street
Boston,
Massachusetts
|
$20.5M |
| 5 |
5
Morgan Stanley
New York
|
$601K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DT
126
Diversified Trust
Memphis,
Tennessee
| – | – | -10,582 | Closed |
|
127
Balyasny Asset Management
Chicago,
Illinois
| – | – | -10,059 | Closed |
|
128
Group One Trading
Chicago,
Illinois
| – | – | -1,800 | Closed |
|
|
ASN
129
Advisory Services Network
Atlanta,
Georgia
| – | – | -412 | Closed |
|
|
MAM
130
Meeder Asset Management
Dublin,
Ohio
| – | – | -92 | Closed |
|
131
Osaic Holdings
Scottsdale,
Arizona
| $0 | 15 | -31 | -67% |
|
|
CFGS
132
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|